阴道二次到第四阶段的阴道 宫内缩用L-PRF治疗
Alberta Greco Lucchina1, Enrico Rescigno2, Canata Alessandra3
1Research Laboratory in Regenerative Medicine and Tissue Engineering, Saint Camillus International University of Health Sciences Rome Italy.
Clinical case reports
|February 27, 2026
概括
这项研究表明,白细胞和血小板丰富的纤维素 (L-PRF) 有效地治疗了患有晚期骨盆器官脱落 (POP) 的老年肥胖患者的子宫. L-PRF为慢性不愈合的阴道提供了一个有希望的,具有成本效益的替代方案.
科学领域:
- 妇科 妇科 妇科 妇科
- 再生医学是一种再生医学.
背景情况:
- 盆腔器官脱落 (POP) 涉及盆腔器官下降到或通过阴道,导致出血,排泄和疼痛等并发症.
- 虽然对年轻患者来说手术是常见的,但患有并发病的老年妇女可能会面临高级POP的挑战.
- 在严重的POP病例中,慢性不愈合的可能会发展,特别是在失禁的情况下,使管理复杂化.
研究的目的:
- 评估白细胞和血小板丰富纤维素 (L-PRF) 在治疗非手术可治疗的,患有第四阶段子宫脱落的老年肥胖患者的子宫的疗效.
主要方法:
- 一名93岁的肥胖女性患者患有第四阶段子宫落和因失禁而导致的多个阴道的治疗.
- 的区域被L-PRF膜透,并用富血小板纤维素 (PRF) 覆盖.
- PRF被和保护,部区域被一个倒置的手套覆盖.
主要成果:
- 病例报告表明,L-PRF对子宫的治疗效果是积极的.
- 这表明L-PRF是与骨盆器官脱落相关的阴道的有希望的治疗方法.
- 与传统带相比,该疗法显示出有效性,安全性和成本效益.
结论:
- L-PRF显示出作为慢性,不治愈的子宫的有效治疗方法的巨大潜力.
- 它比传统的伤口剂更有优势,用于管理POP患者的阴道.
- 这种方法为特定的患者群体提供了可行的,不那么侵入性的选择.
相关概念视频
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
1.0K
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
1.0K
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
258
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
258
01:26Peptic Ulcer Disease IV: Management
576
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
576
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.3K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.3K